<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT02854982</url>
  </required_header>
  <id_info>
    <org_study_id>LIGUE/2014/NH-001</org_study_id>
    <nct_id>NCT02854982</nct_id>
  </id_info>
  <brief_title>Impact on Quality of Life 3 Years After Diagnosis of Prostate Cancer</brief_title>
  <acronym>EPICAP-QALY</acronym>
  <official_title>Impact on Quality of Life 3 Years After Diagnosis of Prostate Cancer</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Centre Hospitalier Universitaire de Nīmes</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Centre Hospitalier Universitaire de Nīmes</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      To study the quality of life of patients with prostate cancer at a distance from their care
      at a time when they are supposed to have taken a &quot;normal&quot; life and compared to subjects
      without cancer prostate of the same age.
    </textblock>
  </brief_summary>
  <overall_status>Enrolling by invitation</overall_status>
  <start_date>September 2015</start_date>
  <completion_date type="Anticipated">January 2018</completion_date>
  <primary_completion_date type="Anticipated">January 2018</primary_completion_date>
  <study_type>Observational</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <observational_model>Cohort</observational_model>
  </study_design_info>
  <primary_outcome>
    <measure>EORTC Quality of Life Questionnaire - Core 30 Score (EORTC QLQ-C30 Score)</measure>
    <time_frame>3 years from diagnosis for cases of prostate cancer and from recruitment for controls</time_frame>
  </primary_outcome>
  <number_of_groups>2</number_of_groups>
  <enrollment type="Anticipated">900</enrollment>
  <condition>Prostatic Neoplasms</condition>
  <condition>Quality of Life</condition>
  <arm_group>
    <arm_group_label>Prostate Cancer</arm_group_label>
    <description>Group drawn of the case group of the case control study, entitled EPICAP</description>
  </arm_group>
  <arm_group>
    <arm_group_label>No Prostate Cancer</arm_group_label>
    <description>Group drawn of the control group of the case control study, entitled EPICAP</description>
  </arm_group>
  <intervention>
    <intervention_type>Procedure</intervention_type>
    <intervention_name>therapeutic management of the prostate Cancer as usual</intervention_name>
    <arm_group_label>Prostate Cancer</arm_group_label>
  </intervention>
  <eligibility>
    <study_pop>
      <textblock>
        Target population: incident cases of prostate cancer
      </textblock>
    </study_pop>
    <sampling_method>Non-Probability Sample</sampling_method>
    <criteria>
      <textblock>
        - exposed group

        Inclusion Criteria:

          -  prostate cancer diagnosed from 1 December 2011 to 31 December 2014

          -  under 75 and residing in the Hérault department at diagnosis

          -  recruited in the EPICAP study

        Exclusion criteria:

          -  having relapsed in the range

          -  non-exposed group:

        Inclusion Criteria:

          -  controls (without prostate cancer) recruited in the EPICAP study

          -  matched to cases on age (5 years)

          -  residing in the Hérault department

        Exclusion criteria:

          -  diagnosis of prostate cancer set in the range
      </textblock>
    </criteria>
    <gender>Male</gender>
    <minimum_age>N/A</minimum_age>
    <maximum_age>75 Years</maximum_age>
    <healthy_volunteers>Accepts Healthy Volunteers</healthy_volunteers>
  </eligibility>
  <verification_date>July 2016</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>August 1, 2016</study_first_submitted>
  <study_first_submitted_qc>August 1, 2016</study_first_submitted_qc>
  <study_first_posted type="Estimate">August 4, 2016</study_first_posted>
  <last_update_submitted>August 1, 2016</last_update_submitted>
  <last_update_submitted_qc>August 1, 2016</last_update_submitted_qc>
  <last_update_posted type="Estimate">August 4, 2016</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Prostatic Neoplasms</mesh_term>
  </condition_browse>
  <patient_data>
    <sharing_ipd>Undecided</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

